(Q35650604)

9 August 2017

title

The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital (English)

1 reference

9 August 2017

Tri A Dinh

1

1 reference

9 August 2017

Esther A Oliva

2

1 reference

9 August 2017

Arlan F Fuller

3

1 reference

9 August 2017

Hang Lee

4

1 reference

9 August 2017

Annekathryn Goodman

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

92

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

648-652

1 reference

Treatment of uterine sarcomas.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Uterine leiomyosarcoma: analysis of treatment failures and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Uterine sarcomas: natural history, treatment and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Phase II trial of paclitaxel in leiomyosarcoma of the uterus: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

Leiomyosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

7 January 2021

Uterine leiomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.044

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2003.10.044

1 reference

9 August 2017

1 reference